1. Home
  2. JAGX vs CHNR Comparison

JAGX vs CHNR Comparison

Compare JAGX & CHNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAGX
  • CHNR
  • Stock Information
  • Founded
  • JAGX 2013
  • CHNR N/A
  • Country
  • JAGX United States
  • CHNR China
  • Employees
  • JAGX N/A
  • CHNR N/A
  • Industry
  • JAGX Biotechnology: Pharmaceutical Preparations
  • CHNR Precious Metals
  • Sector
  • JAGX Health Care
  • CHNR Basic Materials
  • Exchange
  • JAGX Nasdaq
  • CHNR Nasdaq
  • Market Cap
  • JAGX 3.9M
  • CHNR 4.6M
  • IPO Year
  • JAGX N/A
  • CHNR 1995
  • Fundamental
  • Price
  • JAGX $1.77
  • CHNR $3.90
  • Analyst Decision
  • JAGX Strong Buy
  • CHNR
  • Analyst Count
  • JAGX 1
  • CHNR 0
  • Target Price
  • JAGX $60.00
  • CHNR N/A
  • AVG Volume (30 Days)
  • JAGX 147.1K
  • CHNR 18.0K
  • Earning Date
  • JAGX 08-14-2025
  • CHNR 05-15-2025
  • Dividend Yield
  • JAGX N/A
  • CHNR N/A
  • EPS Growth
  • JAGX N/A
  • CHNR N/A
  • EPS
  • JAGX N/A
  • CHNR N/A
  • Revenue
  • JAGX $11,810,000.00
  • CHNR N/A
  • Revenue This Year
  • JAGX $22.41
  • CHNR N/A
  • Revenue Next Year
  • JAGX $30.00
  • CHNR N/A
  • P/E Ratio
  • JAGX N/A
  • CHNR N/A
  • Revenue Growth
  • JAGX 15.96
  • CHNR N/A
  • 52 Week Low
  • JAGX $1.57
  • CHNR $3.16
  • 52 Week High
  • JAGX $35.25
  • CHNR $9.04
  • Technical
  • Relative Strength Index (RSI)
  • JAGX 39.90
  • CHNR 54.53
  • Support Level
  • JAGX $1.60
  • CHNR $3.57
  • Resistance Level
  • JAGX $1.70
  • CHNR $4.24
  • Average True Range (ATR)
  • JAGX 0.12
  • CHNR 0.20
  • MACD
  • JAGX 0.01
  • CHNR 0.05
  • Stochastic Oscillator
  • JAGX 37.04
  • CHNR 59.04

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

About CHNR China Natural Resources Inc.

China Natural Resources Inc is engaged in exploration for lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and exploration of attractive opportunities in other sectors. The company has a single operating segment: exploration and mining.

Share on Social Networks: